A catalytic bioscavenger for the therapeutic and prophylactic defense against recognized chemical threat agents has been a long-standing objective of civilian and military research. Among the toxic agents, organophosphate molecules and cyanide have been widely studied. In order to overcome the limitations of traditional antidotal therapies, isolated, purified, recombinant enzymes with bacterial origin possessing fast catalytic activity were used in in vitro and in vivo experiments. However, the fast degradation, excretion and adverse immunologic reaction against enzymes limit their in vivo use. Development of biodegradable, nontoxic carrier systems, microparticles, and nanoparticles—offering advantageous pharmacokinetic parameters was suggested. Present work deals with the perspectives of carrier systems, such as resealed and annealed erythrocytes and sterically stabilized liposomes. Dendritic polymers and polymer-conjugated enzymes, being in the focus of extensive research efforts nowadays, are also discussed.
AbuchowskiAMcCoyJRPalczukNCVan EsTDavisFF (1977) Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. Journal of Biological Chemistry252
(11): 3582–3586.
2.
AshaniYRothshildNSegallYLevanonDRavehL (1991) Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compound in mice. Life Sciences49
(5): 367–374.
3.
BanghamAD (1963) Physical structure and behaviour of lipids and lipid enzymes. Advances Lipid Research1: 65–104.
4.
BarenholzY (2001) Liposome application: problems and prospects. Current Opinion in Colloid and Interface Science6: 66–77.
5.
BaskinSIPorterDWRockwoodGARomanoJAPatelHCKiserRC (1999) In vitro and in vivo comparison of sulfur donors as antidotes to acute cyanide intoxication. Journal of Applied Toxicology19
(3): 173–183.
6.
BordoDDeriuDColnaghiRCarpenAPaganiSBolognesiM (2000) The crystal structure of sulfurtransferase from Azobacter vinelandii highlights the evolutionary relationship between the rhodanese and phosphate enzyme families. Journal of Molecular Biology298
(4): 691–704.
7.
BroomfieldCAMaxwellDMSelanaRPCastroCAFingerAVLenzDE (1991) Protection by butyrylcholinestarase against organophosphorus poisoning in nonhuman primates. Journal of Pharmacology and Experimental Therapeutics259
(2): 633–638.
8.
BroomfieldCA (1992) A purified recombinant phosphotriesterase protects mice against soman. Pharmacology and Toxicology70
(1): 65–66.
9.
BudaiMChapelaPGrófPZimmerAWalesMEWildJR (2009). Physico-chemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzyme. Journal of Lipid Research19
(2): 163–168.
10.
CannonEPLeungPHawkinsAPetrikovicsIDeLoachJWayJL (1994) Antagonism of cyanide intoxication with murine carrier erythrocytes containing bovine rhodanese and sodium thiosulfate. Journal of Toxicology and Environmental Health41
(3): 267–274.
11.
CerasoliDMGriffithEMDoctorBPSaxenaAFederkoJMGreighNH (2005) In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger. Chemico-Biological Interaction157: 363–365.
12.
ChapmanAPAntoniwPSpitaliMWestSStephensSKingDJ (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nature Biotechnology17
(8): 780–783.
13.
ChengTHarveySPDeFrankJJPetrikovicsIRastogiVK (2004) Bacterial enzymes–potential applications for personell/casualty decontamination against G, V, and HD chemical agents. In: FloraSJSRomanoJABaskinSISekharK (eds) Pharmacological Perspectives of Toxic Chemicals and Their Antidotes. New Delhi: Narosa Publishing House, 87–95.
14.
CohenOKronmanCChitlaruTOrdentlichAVelanBShaffermanA (2001) Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity. Biochemical Journal357
(pt 3): 795–802.
15.
DeakinSPJamesRW (2004) Genetic environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clinical Science107
(5): 435–437.
16.
DooleyTPNairSKGarciaRTCourtneyBC (1995) Mouse rhodanese gene (Tst):cDNA cloning, sequencing, and recombinant protein expression. Biochemical and Biophysical Research Communication216
(3): 1101–1109.
17.
DraganovDITeiberJFSpeelmanAOsawaYSunaharaRLa DuBN (2005) Human paraoxonases (PON1, PON2, PON3) are lactonases with overlapping and distinct substrate specificities. Journal of Lipid Research46
(6): 1239–1247.
18.
FrankenbergL (1980) Enzyme therapy in cyanide poisoning: effect of rhodanese and sulfur compounds. Archives of Toxicology45
(4): 315–323.
19.
FurlongCERichterRJChaplineCCrabbJW (1991) Purification of rabbit and human serum paraoxonase. Biochemistry30
(42): 10133–10140.
20.
HuangY-JHuangYBaldassarreHWangBLazarisALeducM (2007) Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proceedings of the National Academy of Sciences104
(34): 13603–13608.
21.
IhlerGMGlewRHSchnureFM (1973) Enzyme loading erythrocytes. Proceedings of the National Academy of Sciences70
(9): 2663–2666.
22.
KronmanCCohenOMazorOOrdentlichARavehLVelanB (2010) Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338A-HuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics. Chemico-Biological Interactions187
(1–3): 253–258.
23.
La DuBN (2002) Historical considerations. In: CostaLGFurlongCE (eds) Paraoxonases (PON1) in Health and Disease, Basic and Clinical Aspects. Boston, MA: Kluwer Academic Press, 53–77.
24.
LenzDEYeungDSmithJRSneeneyRELumleyLACerasoliDM (2007) Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology233
(1–3): 31–39.
25.
LeungPCannonEPPetrikovicsIHawkinsAWayJL (1991a) In vivostudies on rhodanese encapsulation in mouse carrier erythrocytes. Toxicology and Applied Pharmacology110
(2): 268–274.
26.
LeungPDavisRWYaoCCCannonEPWayJL (1991b) Rhodanese and sodium thiosulfate encapsulated in mouse carrier erythrocytes. Fundamental and Applied Toxicology16
(3): 559–566.
27.
LiWWCostaLGRichterRJHagenTShihDMTwardA (2000) Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics10
(9): 767–780.
28.
MassonPChatonnetALockridgeO (1990) Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant. FEBS Letters262
(1): 115–118.
29.
McGuinnWDBaxterLPeiLPetrikovicsICannonEPWayJL (1994) Antagonism of lethal effects of cyanide by synthetic water-soluble cobalt(III) porphyrin compound. Fundamental and Applied Toxicology23
(1): 76–80.
30.
NovikovBNGrimsleyJKKernRJWildJRWalesME (2010) Improved pharmacokinetics and immunogenicity profile of organophosphorus hydrolase by chemical modification with polyethylene glycol. Journal of Controlled Release146
(3): 318–325.
31.
PapahadjopoulosDAllenTMGabizonAMayhewKMatthayKHuangSK (1991) Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proceedings of the National Academy of Sciences (USA) 88
(24): 11460–11464.
32.
PeiLOmburoGMcGuinnWDPetrikovicsIDaveKRaushelFM (1994) Encapsulation of phosphotriesterase within murine erythrocytes. Toxicology and Applied Pharmacology124
(2): 296–301.
33.
PeiLPetrikovicsIWayJL (1995) Antagonism of the lethal effect of paraoxone by carrier erythrocytes containing organophosphorous acid anhydrase. Fundamental and Applied Toxicology28
(2): 209–214.
34.
PetrikovicsIBaskinSIBeigelKMSchapiroBJRockwoodGAManageABW (2010) Nano-intercalated rhodanese in cyanide antagonism. Nanotoxicology4
(2): 247–254.
35.
PetrikovicsIBudaiMBaskinSIRockwoodGAChildressJBudaiL (2009) Characterization of liposomal vesicles encapsulating rhodanese for cyanide antagonism. Drug Delivery16
(6): 312–319.
36.
PetrikovicsICannonEPMcGuinnWDPeiLWayJL (1995) Cyanide antagonism with organic thiosulfonates and carrier red blood cells containing rhodanese. Fundamental and Applied Toxicology24
(1): 1–8.
37.
PetrikovicsIChengTCPapahadjopoulosDHongKYinRDeFrankJJ (2000a). Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism. Toxicological Sciences57
(1): 16–21.
38.
PetrikovicsIHongKOmburoGHuQZPeiLMcGuinnWD (1999) Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomes. Toxicology and Applied Pharmacology156
(1): 56–63.
39.
PetrikovicsIMcGuinnWDCannonEPPeiLWayJL (1994) Encapsulation of rhodanese and organic thiosulfonates by mouse erythrocytes. Fundamental and Applied Toxicology23
(1): 70–75.
40.
PetrikovicsIMcGuinnWDSylvesterDYuzapavikPJiangJWayJL (2000b) In vitro studies on sterically stabilized liposomes (sl) as enzyme carriers in organophosphorus (op) antagonism. Drug Delivery7
(2): 83–89.
41.
PetrikovicsIWalesMEJaszberenyiJCBudaiMBaskinSISzilasiM (2007) Enzyme-based intravascular defense against organophosphorus neurotoxins: Synergism of dendritic-enzyme complexes with 2-PAM and atropine. Nanotoxicology1
(2): 85–92.
42.
RavehLGrauerEGrunwaldJCohenEAshaniY (1997) The stoichiometry of protection against soman and VX toxicity in monkeys pre-treated with human butyrylcholinestrase. Toxicology and Applied Pharmacology145
(1): 43–53.
43.
SaiduY (2004) Physicochemical features of rhodanese: a review. African Journal of Biotechnology3
(4): 370–374.
44.
SananTTSivaramakrishnanMBeckJMTaoPHayesCJOttoTC (2010) Computational modeling of human paraoxonases-1: preparation of protein models, binding studies, and mechanistic insights. Journal of Physical Organic Chemistry23
(4): 357–369.
45.
TomaliaDABakerHDewaldJHallMKallosGMartinS (1985) A new class of polymers-starburst-dendritic macromolecules. Polymer Journal17
(1): 117–132.
46.
TomaliaDAEsfandR (1997) Dendrons, dendrimers and dendrigrafts. Chemistry and Industry11: 416–420.
47.
VeroneseFMMonfardiniCCalicetiPSchiavonOScrawenMDBeerD (1996) Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethyleneglycol). Journal of Controlled Release40
(3): 199–209.
48.
WayJL (1983) Cyanide antagonism. Fundamental and Applied Toxicology3
(5): 383–386.
49.
WayJL (1984) Mechanism of cyanide intoxication and its antagonism. Annual Review of Pharmacology and Toxicology24: 451–481.
50.
WayJLCannonELeungPDavisRMcGuinnDYaoC (1991) Antagonism of cyanide intoxication with rhodanese encapsulated within resealed erythrocytes. Advances in the Bioscience81: 207–211.
51.
WayJLLeungPRayLSounderC (1985) Erythrocyte-encapsulated thiosulfate sulfurtransferase. Bibliotheca Haematoligica51: 75–81.
52.
WayJLPeiLPetrikovicsIMcGuinnDTamulinasCHuQZ (1997) Organophosphorus antagonism by resealed erythocytes containing recombinant paraoxonase. In: SprandelUWayJL (eds) Erythrocytes as Drug Carriers in Medicine. New York, NY: Plenum Press, 89–92.
53.
XiaXHuZGaoJQinDDurstHDYinR (2002) Light scattering study of the self-association behavior of long chain branched poly(2-ethyloxazoline) in solvents. Langmuir18
(22): 8302–8308.
54.
YinRQinDTomaliaDAKukowsky-LatalloJBakerJR (1997).
From dendrimers to dendrigrafts. Synthesis, characterization and applications. Polymer Materials: Science and Engineering77: 206–207.
